ISMAR-study presentation: in-hospital epidemiology and clinical management of respiratory and cardiac comorbidities in cardiac and respiratory disease units

被引:0
作者
Tramarin, Roberto [1 ]
Polverino, Mario [2 ]
Volterrani, Maurizio [3 ]
Girardi, Bruna [1 ]
Chimini, Claudio [4 ]
Ambrosino, Nicolino [5 ]
De Benedetto, Fernando [6 ]
Proto, Cesare [4 ]
机构
[1] IRCCS Policlin San Donato Care & Res Inst, Div Cardiac Rehabil, Piazza Malan 1, I-20097 Milan, Italy
[2] Scarlato Hosp, High Specialty Prov Pulmonol Unit, Scafati, SA, Italy
[3] IRCCS San Raffaele Pisana Care & Res Inst, Div Cardiac Rehabil, Rome, Italy
[4] St Anna Hosp, Div Cardiol, Brescia, Italy
[5] Univ Hosp Auxilium Vitae, Div Pneumol, Volterra, Italy
[6] Ss Annunziata Hosp, Div Pneumol, Chieti, Italy
关键词
Comorbidity; Diagnostic procedure; Epidemiology; In-hospital; Management; Treatment;
D O I
10.1186/2049-6958-9-28
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Cardiovascular and respiratory diseases are leading causes of morbidity and their co-occurrence has important implications in mortality and other outcomes. Even the most recent guidelines do not reliably address clinical, prognostic, and therapeutic concerns due to the overlap of respiratory and cardiac diseases. Study objectives and design: In order to evaluate in the reality of clinical practice the epidemiology and the reciprocal impact of cardio-pulmonary comorbidity on the clinical management, diagnostic workup and treatment, 1,500 cardiac and 1,500 respiratory inpatients, admitted in acute and rehabilitation units, will be enrolled in a multicenter, nationwide, prospective observational study. For this purpose, each center will enroll at least 50 consecutive patients. At discharge, data analysis will be aimed at the definition of cardiac and pulmonary inpatient comorbidity prevalence, demographic characteristics, length of hospital stay, and risk factors, taking into account also procedures, pharmacological and non-pharmacological treatment, and follow up in patients with cardio-respiratory comorbidity. Conclusions: The purely observational design of the study aims to give new relevant information on the assessment and management of overlapping patients in real life clinical practice, and new insight for improvement and implementation of current guidelines on the management of individual diseases.
引用
收藏
页数:5
相关论文
共 8 条
[1]   Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases - Implications for pay for performance [J].
Boyd, CM ;
Darer, J ;
Boult, C ;
Fried, LP ;
Boult, L ;
Wu, AW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (06) :716-724
[2]   The association between COPD and heart failure risk: a review [J].
de Miguel Diez, Javier ;
Chancafe Morgan, Jorge ;
Jimenez Garcia, Rodrigo .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 8 :305-312
[3]   Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure [J].
Le Jemtel, Thierry H. ;
Padeletti, Margherita ;
Jelic, Sanja .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (02) :171-180
[4]   Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease [J].
Mancini, G. B. John ;
Etminan, Mahyar ;
Zhang, Bin ;
Levesque, Linda E. ;
FitzGerald, J. Mark ;
Brophy, James M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (12) :2554-2560
[5]   Impact of statins and ACE inhibitors on mortality after COPD exacerbations [J].
Mortensen, Eric M. ;
Copeland, Laurel A. ;
Pugh, Mary Jo V. ;
Restrepo, Marcos I. ;
de Molina, Rosa Malo ;
Nakashima, Brandy ;
Anzueto, Antonio .
RESPIRATORY RESEARCH, 2009, 10
[6]   Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension [J].
Stefan, Mihaela S. ;
Rothberg, Michael B. ;
Priya, Aruna ;
Pekow, Penelope S. ;
Au, David H. ;
Lindenauer, Peter K. .
THORAX, 2012, 67 (11) :977-984
[7]   Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: An efficacy and safety analysis of SHIFT study [J].
Tavazzi, L. ;
Swedberg, K. ;
Komajda, M. ;
Boehm, M. ;
Borer, J. S. ;
Lainscak, M. ;
Robertson, M. ;
Ford, I. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 170 (02) :182-188
[8]  
World Trade Organization, TOP 10 CAUS DEATH